Latest News about AZN
Recent news which mentions AZN
   AstraZeneca Scores Its First Global Approval For Antibody Evusheld As COVID-19 Treatment
   
  
  
  August 30, 2022
  From Benzinga
 
   Jill Biden tests negative for COVID after rare rebound infection, and U.S. cases are rising in 12 states
   
  
  
  August 30, 2022
  From MarketWatch
 
   Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
   
  
  
  August 29, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 25, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   2 Top Biotech Stocks to Buy for the Long Haul
   
  
  
  August 24, 2022
  From Motley Fool
 
   Sorrento Shares Pop After Interim Data From Lung Cancer Trial
   
  
  
  August 23, 2022
  From Benzinga
 From Benzinga
 From Best Stocks
 From Benzinga
 
   AstraZeneca Slaps Lawsuit Against Former Employee As He Moves To Close Rival: Report
   
  
  
  August 17, 2022
  From Benzinga
 
   Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 16, 2022
  From Benzinga
 
   3 Top Stocks to Invest In Right Now
   
  
  
  August 16, 2022
  From InvestorPlace
 From Benzinga
 
   UK Government Will Not Buy More AstraZeneca's COVID-19 Treatment
   
  
  
  August 16, 2022
  From Benzinga
 From Benzinga
 
   Why Gilead Sciences Stock Was a 5% Winner Today
   
  
  
  August 15, 2022
  From Motley Fool
 From Benzinga
 
   Landmark Drug Pricing Reform Bill Passes Congress House
   
  
  
  August 15, 2022
  From Benzinga
 
   AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study
   
  
  
  August 15, 2022
  From Benzinga
 
   Recap Of Friday's Biotech Catalysts - End Of the Day Summary
   
  
  
  August 12, 2022
  From Benzinga
 
   Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation
   
  
  
  August 12, 2022
  From Benzinga
 
   This Analyst Says Zentalis' Increased Focus On WEE1 Program Is 'Prudent', Slashes Price Target By 37%
   
  
  
  August 10, 2022
  From Benzinga
 
   Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
   
  
  
  August 09, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

